These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8791285)

  • 1. Src homology domains of v-Src stabilize an active conformation of the tyrosine kinase catalytic domain.
    Xu B; Miller WT
    Mol Cell Biochem; 1996 May; 158(1):57-63. PubMed ID: 8791285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713).
    Hjermstad SJ; Peters KL; Briggs SD; Glazer RI; Smithgall TE
    Oncogene; 1993 Aug; 8(8):2283-92. PubMed ID: 7687763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct interaction of v-Src with the focal adhesion kinase mediated by the Src SH2 domain.
    Xing Z; Chen HC; Nowlen JK; Taylor SJ; Shalloway D; Guan JL
    Mol Biol Cell; 1994 Apr; 5(4):413-21. PubMed ID: 8054685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
    Rogers JA; Cheng HY; Smithgall TE
    Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of synthetic peptides containing Tyr-Met-X-Met motifs by nonreceptor tyrosine kinases in vitro.
    Garcia P; Shoelson SE; George ST; Hinds DA; Goldberg AR; Miller WT
    J Biol Chem; 1993 Nov; 268(33):25146-51. PubMed ID: 8227078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple SH2-mediated interactions in v-src-transformed cells.
    Koch CA; Moran MF; Anderson D; Liu XQ; Mbamalu G; Pawson T
    Mol Cell Biol; 1992 Mar; 12(3):1366-74. PubMed ID: 1545818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease specificity of kinase domains: the src-encoded catalytic domain converts erbB into a sarcoma oncogene.
    Chang CM; Shu HK; Kung HJ
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3928-32. PubMed ID: 7732007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Domain interactions in protein tyrosine kinase Csk.
    Sondhi D; Cole PA
    Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of the SH3 domain of Src interferes with regulation by the phosphorylated carboxyl-terminal tyrosine.
    Okada M; Howell BW; Broome MA; Cooper JA
    J Biol Chem; 1993 Aug; 268(24):18070-5. PubMed ID: 7688738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine phosphorylation of connexin 43 by v-Src is mediated by SH2 and SH3 domain interactions.
    Kanemitsu MY; Loo LW; Simon S; Lau AF; Eckhart W
    J Biol Chem; 1997 Sep; 272(36):22824-31. PubMed ID: 9278444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase.
    Mayer BJ; Baltimore D
    Mol Cell Biol; 1994 May; 14(5):2883-94. PubMed ID: 8164650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the Src homology domains in morphological transformation by v-src.
    Tian M; Martin GS
    Mol Biol Cell; 1997 Jul; 8(7):1183-93. PubMed ID: 9243500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases.
    Mayer BJ; Hirai H; Sakai R
    Curr Biol; 1995 Mar; 5(3):296-305. PubMed ID: 7780740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphopeptide occupancy and photoaffinity cross-linking of the v-Src SH2 domain attenuates tyrosine kinase activity.
    Garcia P; Shoelson SE; Drew JS; Miller WT
    J Biol Chem; 1994 Dec; 269(48):30574-9. PubMed ID: 7527032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intramolecular interaction between SH2-kinase linker and kinase domain is essential for the catalytic activity of protein-tyrosine kinase-6.
    Kim HIe; Lee ST
    J Biol Chem; 2005 Aug; 280(32):28973-80. PubMed ID: 15961400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous assay of Src SH3 and SH2 domain binding using different wavelength fluorescence polarization probes.
    Lynch BA; Minor C; Loiacono KA; van Schravendijk MR; Ram MK; Sundaramoorthi R; Adams SE; Phillips T; Holt D; Rickles RJ; MacNeil IA
    Anal Biochem; 1999 Nov; 275(1):62-73. PubMed ID: 10542110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophosphorylation induces autoactivation and a decrease in the Src homology 2 domain accessibility of the Lyn protein kinase.
    Sotirellis N; Johnson TM; Hibbs ML; Stanley IJ; Stanley E; Dunn AR; Cheng HC
    J Biol Chem; 1995 Dec; 270(50):29773-80. PubMed ID: 8530369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
    Tian M; Martin GS
    Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
    Eck MJ; Atwell SK; Shoelson SE; Harrison SC
    Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the SH2 binding specificity and kinase activity of Src by tyrosine phosphorylation within its SH2 domain.
    Stover DR; Furet P; Lydon NB
    J Biol Chem; 1996 May; 271(21):12481-7. PubMed ID: 8647855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.